Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Demonstration and Dissemination Projects (R18)
Project #
3R18DA006082-03S1
Application #
3441572
Study Section
Special Emphasis Panel (SRCD (01))
Project Start
1989-09-30
Project End
1994-08-31
Budget Start
1992-07-15
Budget End
1992-08-31
Support Year
3
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Friends Research Institute, Inc.
Department
Type
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Ling, W; Shoptaw, S (1997) Integration of research in pharmacotherapy for addictive disease: where are we? Where are we going? J Addict Dis 16:83-102
Ling, W; Wesson, D R; Charuvastra, C et al. (1996) A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry 53:401-7
Compton, P A; Ling, W; Wesson, D R et al. (1996) Urine toxicology as an outcome measure in drug abuse clinical trials: must every sample be analyzed? J Addict Dis 15:85-92
Ling, W; Rawson, R A; Compton, M A (1994) Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine. J Psychoactive Drugs 26:119-28
Wesson, D R; Ling, W; Smith, D E (1993) Prescription of opioids for treatment of pain in patients with addictive disease. J Pain Symptom Manage 8:289-96
Gawin, F H (1991) Cocaine addiction: psychology and neurophysiology. Science 251:1580-6
Rawson, R A; Ling, W (1991) Opioid addiction treatment modalities and some guidelines to their optimal use. J Psychoactive Drugs 23:151-63
Wesson, D R; Smith, D E (1990) Prescription drug abuse. Patient, physician, and cultural responsibilities. West J Med 152:613-6